Table 1 Demographic details

From: Determinants of treatment response in first-episode psychosis: an 18F-DOPA PET study

Variable

Total patient sample (N=26)

Responders (N=13)

Non-responders (N=13)

Controls (N=14)

p-value

Gender (M;F)

22;4

10;3

12;1

10;4

 

Age, yearsa

25.31 (4.61)

24.38 (3.02)

26.23 (5.78)

24.29 (4.62)

p = 0.48

Ethnicity

 White

11

5

6

8

 

 Black

9

4

5

3

 

 Indian

2

2

0

2

 

 Other

4

2

2

1

 

Duration of illness, monthsb

19 (25.5)

12.5 (20.3)

24 (35)

n/a

p = 0.08

Antipsychotic naive, n (%)/

14 (53.8%)/

9 (69.2%)/

5 (38.5)/

  

Free, n (%)

9 (34.6%)

3 (23.1%)

6 (46.2%)

  

Minimally treated, n (%)

3 (11.5%)

1 (7.7%)

2 (15.4%)

  

Injected

146.02

144.62

147.41

146.92

p = 0.79

Activity, MBqc

(12.1)

(6.25)

(16.18)

(7.92)

 

Smoking status

 Current

14 (53.8%)

9 (69.2%)

5 (38.5%)

3 (21.4%)

 

 smoker

4 (15.4%)

1 (7.7%)

3 (23.1%)

3 (21.4%)

 

 Past smoker

8 (30.8%)

3 (23.1%)

5 (385%)

8 (57.1%)

 

 Never smoker

     
  1. aAge is reported as mean (SD)
  2. bDuration of illness is reported as Median (IQR)
  3. cInjected Activity is reported as mean (SD)